Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

Abstract Background Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among men diagnosed with prostate cancer. Piperlongumine (PL) is a novel potential anticancer agent that has been demonstrated to exhibit anticancer efficacy against prostate cancer cells. Howeve...

Full description

Bibliographic Details
Main Authors:	Ding-fang Zhang, Zhi-chun Yang, Jian-qiang Chen, Xiang-xiang Jin, Yin-da Qiu, Xiao-jing Chen, Hong-yi Shi, Zhi-guo Liu, Min-shan Wang, Guang Liang, Xiao-hui Zheng
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Series:	BMC Complementary Medicine and Therapies
Subjects:	Castration-resistant prostate cancer Piperlongumine Cancer migration DNA damage DNA repair DNA damage response
Online Access:	https://doi.org/10.1186/s12906-021-03369-0

Similar Items

PARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical Development
by: Verneri Virtanen, et al.
Published: (2019-07-01)

Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate Cancer
by: Jacob J. Adashek, et al.
Published: (2019-08-01)

Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
by: Kasey Jividen, et al.
Published: (2018-10-01)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
by: LeVee A, et al.
Published: (2021-09-01)

Effect of cisplatin on metastatic castration-resistant prostate cancer with BRCA2 mutation: A case report
by: Dai Koguchi, et al.
Published: (2021-09-01)

Targeting DNA Damage Response in Prostate and Breast Cancer
by: Antje M. Wengner, et al.
Published: (2020-11-01)

New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
by: Gaetano Aurilio, et al.
Published: (2020-06-01)

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
by: Jia-Rong Huang, et al.
Published: (2020-11-01)

Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
by: Vincenzo Di Nunno, et al.
Published: (2018-09-01)

Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction
by: Elena Clementi, et al.
Published: (2020-03-01)

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer
by: Xing-Wei Nan, et al.
Published: (2019-11-01)

Exploring the links between cancer and placenta development
by: Vincenzo Costanzo, et al.
Published: (2018-06-01)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
by: Alessia Cimadamore, et al.
Published: (2021-07-01)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
by: Jong-Lyul Park, et al.
Published: (2018-09-01)

Autophagy Roles in Genome Maintenance
by: Susanna Ambrosio, et al.
Published: (2020-07-01)

BRCA2 and Other DDR Genes in Prostate Cancer
by: Paz Nombela, et al.
Published: (2019-03-01)

Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
by: Aruni Ghose, et al.
Published: (2021-09-01)

Piperlongumine inhibits cell growth and enhances TRAIL-induced apoptosis in prostate cancer cells
by: Gorkem Kismali, et al.
Published: (2020-01-01)

DNA damage: from chronic Inflammation to age-related deterioration
by: Anna Ioannidou, et al.
Published: (2016-10-01)

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer
by: Edoardo Francini, et al.
Published: (2021-08-01)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
by: Takashi Babasaki, et al.
Published: (2021-08-01)

MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
by: Ilaria Plantamura, et al.
Published: (2018-09-01)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
by: Itsuto Hamano, et al.
Published: (2020-07-01)

Reactivities Leading to Potential Chemical Repair of Sunlight-Induced DNA Damage: Mechanistic Studies of Cyclobutane Pyrimidine Dimer (CPD) Lesions under Alkaline Conditions
by: Chaturvedi, Ritu
Published: (2021)

Defective DNA repair mechanisms in prostate cancer: impact of olaparib
by: De Felice F, et al.
Published: (2017-03-01)

Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer
by: Senlin Ye, et al.
Published: (2020-10-01)

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
by: Joshua T. Burgess, et al.
Published: (2020-07-01)

The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line
by: Azam Janati Esfahani, et al.
Published: (2017-05-01)

Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
by: Nicholas Sciascia, et al.
Published: (2020-02-01)

How Cells Handle DNA Breaks during Mitosis: Detection, Signaling, Repair, and Fate Choice
by: Ruth Thompson, et al.
Published: (2019-09-01)

Deoxyribonucleic acid damage and repair response in the chemotherapy of lung cancer: cross-sectional study
by: MARCIA R. SCHNEIDER, et al.

ATM in breast and brain tumors: a comprehensive review
by: Mehrdad Asghari Estiar, et al.
Published: (2018-09-01)

DNA damage tolerance in mammalian cells
by: Andersen, Parker Lyng
Published: (2009)

Genome maintenance and transcription integrity in ageing and disease
by: Stefanie eWolters, et al.
Published: (2013-02-01)

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
by: Caroline Molinaro, et al.
Published: (2021-07-01)

Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad and the promising
by: Christian Robert Jekimovs, et al.
Published: (2014-04-01)

ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development
by: Liem Minh Phan, et al.
Published: (2021-05-01)

Mutperiod: Analysis of periodic mutation rates in nucleosomes
by: Benjamin Morledge-Hampton, et al.
Published: (2021-01-01)

Genomic Characterization of Cisplatin Response Uncovers Priming of Cisplatin-Induced Genes in a Resistant Cell Line
by: Hadar Golan Berman, et al.
Published: (2021-05-01)

The multifaceted world of the DNA damage response
by: Antonio ePorro
Published: (2016-05-01)